Oscar B. Lahoud, MD
Bone Marrow Transplant Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Stem Cell Transplantation
- Chimeric Antigen Receptor (CAR) T Cell
- Multiple Myeloma
Request an Appointment
About Me
- Senior Medical Director, Strategic Partnerships
- Medical Site Director, Memorial Medical Care, PC – A practice of MSK physicians
As a hematologist-oncologist, I care for people with blood cancers. I have expertise in treating lymphoma, leukemia, and myeloma and in using advanced therapies, including stem cell transplant and chimeric antigen receptor (CAR) T cells.
I offer my patients a wide range of treatment options whenever possible. This may include the standard of care or promising novel therapies, like immunotherapy or targeted therapy. At Memorial Medical Care, PC and MSK Nassau, I help my patients access the same level of cutting-edge care that makes Memorial Sloan Kettering Cancer Center (MSK) a leader in cancer care.
Read more
When I meet with patients, they are often worried about the possible side effects of treatment. These concerns sometimes arise from information online or from a personal connection’s experience with cancer. I remind my patients that their cancer is unique and will be treated as such. The plans that we put together best fit our patients’ health, life circumstances, and individual goals. We work together to create a treatment plan that considers side effects before treatment starts. This helps patients know what to expect and recognize any side effects that they might experience early.
When I came to MSK in 2012, I was a doctor in the Urgent Care Center. I cared for people who were experiencing side effects from cancer and its treatment. I chose to focus my fellowship on hematologic oncology and blood and bone marrow stem cell transplantation. This training taught me the importance of providing comprehensive care to people with blood cancers. I treat my patients as whole people, not just their disease.
After completing my fellowship, I stayed at MSK as a member of the Adult Bone Marrow Transplant Service. My first goal in this role was to expand access to our world-class transplant expertise to MSK Nassau through the Opening Stem Cell Access to the Regionals (OSCAR) program. This program has allowed our patients in Long Island to receive pre- and post-transplant care locally. Previously, patients needed to travel to Manhattan to receive pre- and post-transplant care.
I believe every person with cancer should have the opportunity to access the expertise and cutting-edge therapies that MSK offers, and I have been devoted to this mission through the OSCAR program. With the support from leadership from the relevant services, division and department, while continuously working to expand transplant and CAR T cell therapy to our other regional sites, as the Medical Site Director for Memorial Medical Care, PC – A practice of MSK physicians, I help bring these services to our new Brooklyn facility in Flatbush.
I also serve as MSK’s Strategic Partnerships Program Senior Medical Director. This program aims to facilitate collaboration between locoregional partners and MSK so patients have comprehensive care coordination between our institution’s cancer experts and a patient’s external providers closer to home.
A bone marrow transplant specialist is a doctor with special training in bone marrow transplants.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Stem Cell Transplantation
- Chimeric Antigen Receptor (CAR) T Cell
- Multiple Myeloma
- Lymphoma
- Leukemia
- Hematologic Malignancies
- Immune Therapies
- Targeted Therapies
- Cancer-Related Emergencies
Education
- MD, University of Michigan Medical School
Residencies
- Internal Medicine – Maimonides Medical Center/Albert Einstein College of Medicine
Fellowships
- Hematology/Oncology – Maimonides Medical Center/Albert Einstein College of Medicine
- Bone Marrow Transplant – Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Lahoud sees patients at three locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Lahoud
- A Phase 2 Study of Daratumumab Plus Bortezomib, Cyclophosphamide, and Dexamethasone in People With Amyloid Light Chain Amyloidosis
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Lahoud’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Oscar B. Lahoud discloses the following relationships and financial interests:
-
MorphoSys AG
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
